S-1 = $4,500,000 Stock Infusion, Direct Purchase

S-1 = $4,500,000 Stock Infusion, Direct Purchase


A word about the S-1 Registration.

It is a different kind of stock buy. Not a Market buy. Where stock and money exchanges hands between a stock buyer and seller. That stock was already originally sold during the IPO. Does not financially benefit HHSE per se.

This S-1 is a DIRECT BUY from HHSE. New stock. (shelf). Every penny of the stock sale goes directly into Treasury of HHSE. Benefits HHSE, because they can invest, leverage into the business. Premium ABOVE Market. $.045 - $.10. This S-1 adds value. Increases HHSE price. Every share of HHSE increases in value.

This is the part that blows my mind. Smart Money is doing the buying. What do you think the investors expect from the stock? Do they want to lose money? OR
Do investors expect HHSE stock to increase in value in the future?

I can not say enough about this cash infusion. Via DD, I know for a fact a lot the issues with the Company has been a lack of Funding. HHSE (CEO with NASDAQ experience) can now Leverage the S-1 into More Profitablilty.





HHSE S-1 REGISTRATION

* Direct Stock Purchase (Accredited Investor Buy Directly From HHSE)
* Cash Infusion (Unlike Market Buys, Monies Go Directly To HHSE Coffers)
* 150% of the VWAP of the HHSE shares
* Significant Premium "ABOVE" Market
* $.045 - $.10
* Potential $4,500,000
* Accretion, NOT Dilution
* HHSE Treasury Available For Corporate Investment








HHSE